Live updates from AMCP Annual Meeting

Event features Caitlin Berry, senior principal of public policy and government affairs at Prime Therapeutics

cover image for 2024 summer report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime Therapeutics Report...

Ahead of her session with Andy Killpack, Liu — senior director of specialty clinical solutions at Prime/MRx — shares current care management strategies for cell and gene therapy and the future of...

Work better Our flexible Hub and Home® program lets employees work in the way that works for them. Breadcrumb Home Careers Hub + Home Flexibility and connections Through our Hub and Home approach,...

Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service

The best care is integrated care People feel and live better when care and medicine work together. Integrated drug management helps lower your total cost of care while boosting employee...

In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.

Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty...

Helping to lower drug costs Effective formularies are one of the best ways to ensure you have the lowest total cost of care, and a well-managed formulary starts with proactive, comprehensive...

AIS Health

The best care is integrated care People feel and live better when care and medicine work together. Integrated drug management helps lower your total cost of care while boosting employee...

One of the Prime Together Foundation’s 2023 grants went to TC Food Justice, which works to reduce food waste and hunger in the Twin Cities by linking those willing to help and those in need.

Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event 

Certification recognizes quality service and continuous improvement

Report features new highlights and rankings of the top 50 drug classes by percent of net spend.

Prime is committed to simplifying the cancer care journey through leading oncology solutions designed to support people with cancer

New report, an evolution of previous DEI reports, aims to demonstrate transparency and accountability for company’s corporate social responsibility journey

Grant helps provide a home away from home for families facing cancer

Develop a holistic GLP-1 strategy An evidence-based approach to GLP-1 drugs helps you implement custom strategies that promote clinically appropriate use and consider affordability, long-term value...

Breadcrumb Home Careers Residency Program Join our residency program The ASHP-accredited Prime Therapeutics PGY1 residency program will allow you to build your best career in managed care. You will...

Help reimagine pharmacy We need the brightest and most passionate people to bring our purpose to life. Search open jobs Breadcrumb Home Careers Work + life in harmony Prime Therapeutics (Prime)...

Notice of privacy practices Effective Date: March 2023 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE...

How Prime Therapeutics/Magellan Rx Management reimagines pharmacy to do what's right.

The event emphasizes additional measures for obesity therapy.

Our journey to reimagine pharmacy We are fueled by the desire to deliver an intuitive, meaningful, affordable experience that customers and members appreciate. By combining our innovation and...

At Pharmacy Benefit Management Institute (PBMI) annual conference, Prime received two awards: one for cost savings, another for leadership.

Report encourages providers to consider health contexts and lifestyle modifications as well as personal preferences and current guidelines when prescribing GLP-1s for weight loss

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

Prime Therapeutics is committed to simplifying the patient journey for those with complex conditions through its industry-leading HighTouchRx product

Tap into solutions that deliver real value The best Medicare and Managed Medicaid programs are ones that are customized to your needs and member population. Let us put our 40+ years of experience...

Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members

See our CSR efforts As outlined in our 2023 Corporate Social Responsibility Report, we're committed to creating sustainable social change, rallying around our common purpose. Read the report...

Tap into our Expert Clinical Network Gain insights from leading key opinion leaders (KOLs) to drive better care. Breadcrumb Home Our solutions Specialty drug management Medical pharmacy Expert...

Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.

Event features discussions about health care industry trends, best practices and innovations

Build healthier communities By delivering affordable, reliable services that help improve health outcomes and coordinate care, we help you get your members the resources they need to live healthier...

California Privacy Notice and Policy Prime Therapeutics LLC and all its divisions and subsidiaries (collectively, (“Company”, “Prime”, “we” or “us”) understands the importance of your privacy and...

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

Urick, senior principal health outcomes researcher, shares more about his Spotlight Session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

Prime Therapeutics researchers share how the model helps to optimize drug therapy and lower costs

Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...

Welcome to Mid-Market Central At Prime Therapeutics (Prime), we value our mid-market partner relationships and continually strive to create exceptional experiences for our customers. This resource...

A look at the specialty landscape and how Prime delivers value to employers

Diversity, equity and inclusion Our commitment to diversity, equity and inclusion (DEI) is rooted in our purpose and dedication to serving others. Breadcrumb Home Who we are Diversity, equity and...

publications Pancreatic cancer: Innovative therapy approved, but unmet need continues April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth...

Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...

Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) High Cost Therapy Profile Gene Therapy/Immunology Marnetegragene autotemcel...

Breadcrumb Home Client Communication Pharmaceutical tariffs: Updates and featured news Pharmaceutical tariffs: Updates & news Your source for updates and featured client news on the evolving U.S....

Managed Markets Insight & Technology (MMIT)

Ben Urick, senior director of health outcomes, and Landon Marshall, health outcomes research principal, share more about their educational session and research poster on GLP-1s

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.

Read Clinical News: August 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA SAFETY ALERT ON COMPOUNDED...

publications GLP-1 Pipeline Update: November 2024 Quarterly view of the GLP-1 pipeline and anticipated indications November 21, 2024 Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Vice...

Publications Clinical Highlights: March 2025 Your monthly source for drug information highlights. March 27, 2025 Trending topics As of late February 2025, the United States (U.S.) Centers for...

publications Quarterly Drug Pipeline: October 2024 Clinical insights and competitive intelligence on anticipated drugs in development October 31, 2025 Editor-in-chief's message Welcome to the Prime...

Quarterly Drug Pipeline: July 2024 Clinical insights and competitive intelligence on anticipated drugs in development Editor-in-chief's message Welcome to the Prime Quarterly Drug Pipeline! Dive...

Quarterly Drug Pipeline: April 2024 Clinical insights and competitive intelligence on anticipated drugs in development Drug Pipeline Clinical insights and competitive intelligence on anticipated...